Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity.
about
Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysisDefinitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.
P2860
Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase II trial of hyperfractio ...... cancer: results and toxicity.
@en
type
label
Phase II trial of hyperfractio ...... cancer: results and toxicity.
@en
prefLabel
Phase II trial of hyperfractio ...... cancer: results and toxicity.
@en
P2093
P1476
Phase II trial of hyperfractio ...... cancer: results and toxicity.
@en
P2093
Antje Ernst-Stecken
Gerhard Grabenbauer
Heinrich Iro
Ludwig Plasswilm
Rolf Sauer
P2888
P304
P356
10.1007/S00066-004-1307-1
P577
2004-12-01T00:00:00Z